Sirtuin 1 (SIRT1)

Overview

Sirtuin 1 (SIRT1) is a highly conserved NAD⁺-dependent deacetylase belonging to the sirtuin family of class III histone deacetylases. It functions as a master metabolic and stress-response regulator, modulating gene expression through post-translational modification of both histone and non-histone protein substrates. SIRT1 removes acetyl groups from lysine residues on target proteins — including TP53, FOXO1, peroxisome proliferator-activated receptor alpha (Peroxisome proliferator-activated receptor alpha (PPARα)), and numerous chromatin-associated factors — thereby influencing downstream programs governing energy homeostasis, oxidative stress defense, inflammation, autophagy, and cell survival. Its catalytic activity is intrinsically coupled to cellular NAD⁺/NADH redox status, making it a direct sensor of metabolic state and a critical node linking nutrient availability to transcriptional output.

SIRT1 exerts broad physiological influence across multiple organ systems. In the nervous system, it suppresses oxidative stress and inflammatory signaling, conferring neuroprotection. In metabolic tissues, it partners with AMP-activated protein kinase (PRKAA1/AMPK) to coordinate energy sensing and mitochondrial quality control, in part through crosstalk with the Mechanistic target of rapamycin (mTOR) (mTOR) and the PI3K/AKT/mTOR pathway. Given its central role in aging-associated processes, SIRT1 has emerged as a compelling target in research spanning neurodegeneration, cancer, reproductive dysfunction, renal disease, and cardiovascular disease.

Recent Publications Summary

Recent studies have continued to position Sirtuin 1 (SIRT1) as a central regulator of energy metabolism, stress responses, inflammation, and mitochondrial homeostasis across diverse disease contexts. In Alzheimer’s disease research, dexmedetomidine was investigated for its protective effects through activation of the AMPK/SIRT1 pathway in a rat model, reflecting interest in SIRT1-linked metabolic signaling in neurodegeneration 42268445Jun. Related work also highlighted SIRT1 in brain redox and inflammatory regulation, with a sunflower oil-based high-fat diet reported to modulate brain antioxidant defense, inflammation, and SIRT1 activity, while L-arginine was described as protective in rats 42201597May. Reviews further connected SIRT1 to autophagy and brain aging, noting that intermittent fasting may promote autophagosome formation through AMPK and Sirtuin 1 pathways 41811567Mar, and that bioactive natural products can influence autophagy via SIRT1 alongside AMPK, PI3K/AKT/mTOR, and FOXO signaling 41830033Mar.

Several publications focused on SIRT1 in mitochondrial regulation and tissue injury. In polycystic ovary syndrome, melatonin was reported to attenuate Drp1-mediated excessive mitochondrial fission by upregulating SIRT1 in granulosa cells, linking SIRT1 to improved mitochondrial dynamics 41949882Apr. In aged mice with calcium oxalate crystal-induced kidney injury, SIRT1 was described as a crucial regulator of worsening mitochondrial dysfunction and fibrosis, acting through PPARα and lipid metabolism pathways 42209799May. In liver ischemia-reperfusion injury, reduced NAD+ levels in aged hepatic macrophages were associated with decreased Sirt1 activity, eIF2α hyperacetylation, endoplasmic reticulum stress, and pro-inflammatory macrophage polarization; β-nicotinamide mononucleotide restored Sirt1 activity and reduced inflammatory cytokine expression 41775225Mar.

SIRT1 was also implicated in cancer biology and protein regulation. A novel LINC00973-encoded microprotein, L3EMP, was reported to promote lung adenocarcinoma progression by catalyzing the deubiquitination of SIRT1, suggesting a tumor-promoting role for SIRT1 stabilization in this setting 41942609Apr. In a computational study of fever-related targets, vernomenin from Vernonia amygdalina showed the strongest predicted binding affinity to SIRT1 among the screened targets, with molecular dynamics simulations suggesting a stable vernomenin-SIRT1 complex and possible allosteric modulation 41691789Feb.

What Changes, What Holds

1. SIRT1-linked metabolic and inflammatory signaling is being extended into neurodegeneration and brain aging, but the core account stands
REINFORCES These studies do not displace SIRT1’s established role as a metabolic and stress-response regulator; they sharpen it by showing that the same AMPK/SIRT1, redox, inflammatory, and autophagy-linked circuitry is being invoked in Alzheimer’s-related and diet/aging brain models 42268445Jun41811567Mar. The main consequence is broader disease-context support for the Overview’s neuroprotective framing, not a new function.

2. SIRT1 now has stronger support as a mitochondrial quality-control node in tissue injury, with NAD⁺ availability emerging as a limiting factor
REINFORCES The new work fits the Overview’s description of SIRT1 as a coordinator of energy homeostasis, autophagy, and mitochondrial maintenance, while adding organ-specific detail in ovary, kidney, and liver injury 41949882Apr42209799May. The most useful update is mechanistic: SIRT1 appears tightly coupled to mitochondrial dynamics, PPARα-linked lipid handling, and inflammatory stress responses, especially when NAD⁺ falls. That extends rather than contradicts the baseline.

3. SIRT1 is also being stabilized or targeted in cancer and in silico screening, but these are context-specific extensions rather than a new role
REINFORCES The lung adenocarcinoma finding adds another example of SIRT1 being regulated by protein modification in tumor biology, which is consistent with the Overview’s broad cancer relevance 41942609Apr. The computational vernomenin result is hypothesis-generating only and does not alter the settled account 41691789Feb. Together, these papers mainly reinforce that SIRT1 remains a plausible therapeutic node, while leaving its direction of benefit or harm highly context dependent.

Overview update candidates: SIRT1’s involvement in Alzheimer’s-related brain redox/inflammatory regulation and autophagy; its role in mitochondrial dynamics; PPARα-linked lipid metabolism; and NAD⁺-dependent inflammatory injury responses; context-specific stabilization in lung adenocarcinoma.